1. An ultrastructural and biochemical study of the toxic and hypoglycaemic effects of hypoglycin and pent-4-enoate was made on the livers of normal and clofibrate-fed rats. 2. Injection of hypoglycin to rats doubles (from 22% to 44%) the volume fraction of mitochondria and decreases (from 1.05% to 0.26%) the volume fraction of peroxisomes in hepatocytes. The fast-acting toxin pent-4-enoate causes few ultrastructural changes except for the accumulation of lipids. 3. In male adult rats fed with 0.5% clofibrate in their diet for 1-2 months, the volume fraction occupied by peroxisomes and mitochondria in hepatocytes rose to 6.26% and 29.5% respectively. Clofibrate feeding apparently protected the animals against the toxic, hypoglycaemic and hypothermic effects of hypoglycin and of pent-4-enoate, and completely prevented the ultrastructural damage caused by hypoglycin. 4. After hypoglycin administration, hepatic mitochondrial butyryl-CoA dehydrogenase activity was inhibited by more than 90% and, surprisingly, the activity of the peroxisomal enzymes studied was largely preserved. 5. When hypoglycin was given to rats fed on a clofibrate-containing diet, the oxidation of decanoylcarnitine, which was incomplete after hypoglycin treatment alone, remained incomplete with uncoupled mitochondria, but became apparently complete with coupled mitochondria. In the latter condition, there was a slowing of the rate during the last quarter of the pulse of oxygen uptake. Further, butyryl-CoA dehydrogenase activity was much less affected by hypoglycin in clofibrate-fed animals. 6. Pent-4-enoate does not inhibit fl-oxidation in coupled mitochondria from clofibrate-treated rats.
by pent-4-enoate, which, however, does not cause a branched-chain organicacidaemia (Billington et al., 1978b) . The onset of hypoglycaemia caused by hypoglycin may take several hours and lasts for up to a further 20h, whereas that caused by pent-4-enoate is more rapid (l-2h) and glycaemia remains low for only 2-3h (Billington et al., 1978b) .
The administration of hypoglycaemic doses of hypoglycin caused ultrastructural changes in rat liver: gross swelling of mitochondria, loss of dense matrix granules and presence of autophagic vacuoles containing mitochondria (Brooks & Audretsch, 1970 , 197 1a,b, 1975 . In parallel with a study of the effects of hypoglycin on carbohydrate metabolism (L. Hue & H. S. A. Sherratt, unpublished work) , the livers from rats given hypoglycin were examined by electron microscopy. It was noticed that, in addition to the changes previously seen by Brooks & Audretsch (1975) , the number of peroxisomes in hepatocytes was decreased by approx. 70%. It was therefore decided to give hypoglycin and pent-4-enoate to rats that had been fed with the hypolipidaemic drug clofibrate [Atromid S; ethyl 2-(4-chlorophenoxy)isobutyrate], since it is known that clofibrate causes in hepatocytes a large increase in both the volume fraction of peroxisomes and the activity of peroxisomal fl-oxidation of fatty acids (Lazarow & de Duve, 1976; Lazarow, 1978; Mannaerts et al., 1978) . It was found that clofibrate gave very efficient protection against the toxic, hypoglycaemic and hypothermic effects of hypoglycin and pent-4-enoate. Parts of this work have been presented at various scientific meetings , 1980a .
Materials and methods

Materials
Hypoglycin was prepared from ackee seeds as described by Billington & Sherratt (1981) . enoate was from Fluka, Buchs, Switzerland.
Butyryl-CoA and decanoyl(-)-carnitine were prepared and characterized as described by and by respectively. Clofibrate and nafenopin were gifts from Imperial Chemical Industries Ltd. and CibaGeigy respectively. Other biochemicals were obtained from Boehringer Corp. or Sigma Chemical Co.
Animals
Male albino Wistar rats (approx. 200g at the start of the experiments) were used. They were fed on a solid diet made by mixing 1 kg of powdered laboratory-animal chow with 500ml of a warm solution of 10% (w/v) gelatin in water, with or without 5 ml of clofibrate. Rats were maintained with a 12h-light/12h-darkness cycle.
Design of the experiments
All animals were starved at least for 24h before being killed, and were injected intraperitoneally with hypoglycin (80mg/kg body wt.) after 9h of fasting, or with pent-4-enoate (300 mg/kg body wt.) or with 0.15M-NaCl, after 23 h of fasting. After anaesthesia (Nembutal, 60mg/kg intraperitoneally) the rectal temperatures were measured, the abdomen was opened, blood samples were taken for measurement of blood glucose concentrations, and samples of liver were directly taken for electron microscopy, for the preparation of mitochondrial fractions, or were freeze-clamped for further biochemical studies.
Electron microscopy and morphometry
Liver samples were either fixed directly in 2% (w/v) OS04 or prefixed in 2% (v/v) glutaraldehyde. After dehydration, they were embedded either in Epon or in the mixture described by Spurr (1969) . Ultrathin sections, stained with uranyl acetate and lead citrate, were examined with a Philips EM-301 electron microscope. The morphometric analysis of micrographs taken at a constant magnification of x 18000 was performed by the method and with the computer program designed by Baudhuin (1974) . Additional description of this technique has been reported (Aubert-Tulkens et al., 1979) .
Preparation of mitochondrial fractions
The livers were homogenized in 5 vol. of 0.25M-sucrose/2mM-Hepes/0. 1 mM-EDTA, at pH 7.2. The homogenate was centrifuged at 0-4°C for 3min at 1000g, and the supernatant was then centrifuged at 17 300g for 5min to sediment the mitochondrial fraction (mitochondria, lysosomes, peroxisomes) . This fraction was washed once, and finally suspended in the homogenization medium to give 40mg of protein/ml. Mitochondrial fractions were kept at 0°C and used within 4h.
Measurement of mitochondrial P-oxidation
Oxygen uptake by mitochondrial fractions was measured polarographically at 30°C and pH 7.2 in a final volume of 2.3ml containing 1-5mg of protein, 120mM-KCl/5mM-Hepes/5mM-MgCl2/ 2.5mM-potassium phosphate/l mM-EDTA and 5mM-malonate to prevent oxidation of acetylCoA. Decanoylcarnitine (20 UM) was used as a substrate. To obtain coupling conditions 0.5 mM-ADP was also added, and for uncoupling conditions, 20M-2,4-dinitrophenol and 10mM-arsenate were included . During acylcarnitine oxidation, endogenous respiration is apparently suppressed (Lopez-Cardozo & van den Bergh, 1972; Osmundsen & Sherratt, 1975) . Under these conditions, fatty acyl groups are quantitatively oxidized to acetoacetate or to acetoacetate plus butyrate, and the oxygen uptake is a direct measure of f-oxidation (Sherratt & Osmundsen, 1976) . The reaction may be written: 2 Decanoylcarnitine + 8 02 5 acetoacetate + 2 carnitine and when butyryl-CoA dehydrogenase is inactivated by hypoglycin metabolites: 2 Decanoylcarnitine + 6 02 -_ 3 acetoacetate + 2 butyrate + 2 carnitine The oxygen uptake by all mitochondrial fractions was completely inhibited by 1 mM-NaCN. Extraction and assay of acyl-CoA dehydrogenase Freeze-clamped livers or pelleted mitochondrial fractions were homogenized at 0°C in 4 vol. of 1 .0M-KCl /40mM-potassium phosphate (pH 7.4)/0.5% (v/v) Triton X-100, and the resulting extracts were centrifuged at 150000g,V. for 60min.
The supernatant contained the acyl-CoA dehydrogenases, and some dispersed lipids, which interfered with the assays. These lipids were extracted by four washes with an equal volume of peroxidefree ether. The apparent acyl-CoA dehydrogenase activity (EC 1.3.99.-) was assayed with butyrylCoA as a substrate, as described by . Assay ofperoxisomal enzymes Peroxisomal enzymes were assayed in freezeclamped liver samples. Catalase activity (EC 1.11.1.6) was assayed by the titanium sulphate procedure (Baudhuin et al., 1964) . Urate oxidase (EC 1.7.3.3) and other H202-generating oxidases were assayed in the presence of 80mM-glycylglycine buffer, pH8.3, by following fluorimetrically the production of H202 as described by Vamecq & Van Hoof (1984 (Huggett & Nixon, 1957) , and protein was determined by the method of Lowry et al. (1951) , with bovine serum albumin as a standard.
Results
Effects of clofibrate feeding on the toxicity of hypoglycin and ofpent-4-enoate
In all animals fed on a normal diet, the administration of hypoglycin caused severe prostration, hypoglycaemia (blood [glucose] = 1-3 mM) and hypothermia (rectal temperature < 30°C). The dose given was in the region of the LD50 for the strain of rats. The dose of pent-4-enoate injected was generally fatal within 60min in fasted rats. Animals given 0.5% clofibrate in their diet appeared normal, except for a smaller gain of weight (15% less than controls after 2 weeks). The protective effect of clofibrate (feeding for 3 weeks or more) was striking: animals injected with hypoglycin or pent-4-enoate appeared virtually normal, and the hypoglycaemic and hypothermic effects of these toxins were completely prevented (blood [glucose] > 5 mM, rectal temperature > 350C). The development of resistance to pent-4-enoate is shown in Table 1 . It suggests that individual animals became resistant at different times, and that either they died or they survived without apparently showing any symptom. When after 18 days clofibrate feeding was discontinued, it took about 2 weeks before sensitivity to pent-4-enoate was restored in all animals, again with an apparent all-or-nothing response (Table 1) . In a preliminary experiment, feeding another hypolipidaemic drug, nafenopin {2-methyl-2-[4-(1,2,3,4-tetrahydro-1-naphthyl)phenoxy]propionic acid}, which also causes peroxisomal proliferation (Staubli et al., 1977) , protected rats against the toxic and morphological effects of hypoglycin (results not shown). Ultrastructure and morphometry ( The first rat was fasted for 24h after having beenl given the clofibrate-containing diet for 1 day. aind was then given 0.2M-sodium pent-4-enoate (300 mg/ kg body wt.) intraperitoneally. Control rats were also fasted for 24h and matched for age and weight. The administration of clofibrate was discontinued after 18 days and rats were fed on a control diet.
No Vol. 229 Vol. 229 391 (a) were swelling of mitochondria, decrease in the number of peroxisomes and an increased number and size of fat droplets. Peroxisomes were scarce, but they usually appeared normal. In clofibrate-fed animals which resisted the effects of hypoglycin, the liver ultrastructure remained unchanged, except for rare images of stacking of mitochondrial cristae. This protective effect was, however, only consistently obtained when the treatment with clofibrate was longer than 1 month. In an experiment in which two clofibratefed animals had only increased the volume fraction of their liver peroxisomes to 2.40% and 2.64% respectively (results not shown in Table 2 ), administration of hypoglycin, although failing to elicit any clinical symptom, increased the volume fraction occupied by fat droplets in hepatocytes from 0.21 to 5.27%, without change in the volume fraction of the mitochondria.
Effects of pent-4-enoate. Few obvious effects of pent-4-enoate on liver ultrastructure were seen except for a dramatic increase in the number, size and osmiophily of fat droplets in hepatocytes. As noted above, previous clofibrate feeding for a few weeks completely protected the animals but, in this case, with a 5-fold increase in the average volume of peroxisomes (0.470pm3).
Biochemical results
Butyryl-CoA dehydrogenase. The almost complete inhibition (90%) of butyryl-CoA dehydrogenase activity in the livers of normal rats given hypoglycin (Billington et al., 1978a,b) was confirmed. There was a 2.4-fold increase in the specific activity of liver butyryl-CoA dehydrogenase as a result of clofibrate feeding. When hypoglycin was given to clofibrate-fed rats, butyryl-CoA dehydrogenase activity was lowered by only 50-70% and went back to control values (1.54 + 0.26 as compared with 1.40 units/g of liver in controls).
Effects of clofibrate feeding on the inhibition of mitochondrial fl-oxidation by hypoglycin. The expected incomplete oxidation of decanoylcarnitine (75% of the theoretical value) by coupled or uncoupled liver mitochondria from untreated rats after administration of hypoglycin (Osmundsen & Sherratt, 1975) was confirmed. By contrast, coupled mitochondrial fractions from the livers of clofibrate-fed rats given hypoglycin displayed an unusual pattern of decanoyl-carnitine oxidation with biphasic kinetics (Figs. 3b and Sa). Indeed, decanoylcarnitine was apparently completely oxidized to acetoacetate, but with a progressive slowing of the rate towards the end of the pulse of oxygen uptake, which started after about 75% of the theoretical oxygen uptake had occurred (Fig.  3b) ; when uncoupled, the same mitochondrial preparations incompletely oxidized decanoylcarnitine (Fig. 4b) .
Effects of clofibrate feeding on the inhibition of mitochondrial P-oxidation bypent-4-enoate. Uncoupled mitochondria were not used, since formation of pent-4-enoyl-CoA is necessary for the inhibition of fl-oxidation . The inhibition (up to 85% in our experiments) by 1 mMpent-4-enoate of the decanoylcarnitine oxidation in coupled mitochondrial fractions from untreated rat livers was minimal or absent in mitochondrial fractions from clofibrate-fed rats (Fig. 6 ). Metabolites of pent-4-enoate do not inhibit butyryl-CoA dehydrogenase (results not shown; Billington et al., 1978a) . They affect only the rate, but not the stoichiometry, of oxygen consumption when fatty acids are being oxidized (Billington et al., 1978a,b) . Clofibrate feeding did not increase the very small oxygen uptake which follows the addition of pent-4-enoate Fig. 3 . Stoichiometry of the oxidation of decanoylcarnitine by coupled liver mitochondria To obtain coupling conditions, 0.5mM-ADP was added to the medium, or 20pM-2,4-dinitrophenol and 10mM-arsenate for uncoupled mitochondria. Other experimental details are given in the Materials and methods section. to mitochondrial fractions, as reported by (about 2-fold) caused by clofibrate were not affected by the further administration of hypoglycin to these animals.
Discussion
Feeding clofibrate induces several changes in the liver of rats. In addition to the induction of peroxisomes (for a review, see Reddy & Lalwani, 1983) and of peroxisomal fl-oxidation (Lazarow, 1978) , it increases the total capacity for mitochondrial fl-oxidation (Mannaerts et al., 1978) , particularly the oxidation of medium-chain and shortchain acyl-carnitine esters . The total liver content of CoA and carnitine is increased 3-fold (Mannaerts et al., 1978) and the concentration of the cytosolic fatty-acid-binding Z-protein is doubled (Renaud et al., 1978) . These appear to be co-ordinated changes, which allow the liver to metabolize very-long-chain fatty acids more effectively . We show here that hypoglycin toxicity is accompanied by a large diminution in the number of peroxisomes in hepatocytes. Clofibrate protects animals against this toxin as well as against pent-4-enoate, but this protection is neither complete (organic aciduria is only partially prevented; H. S. A. Sherratt & R. R. Veitch, unpublished work) nor appears from our data to result primarily from the proliferation of peroxisomes.
Ultrastructural changes
The ultrastructural changes observed in the liver after hypoglycin treatment confirm the previous reports by Brooks & Audretsch (1970 , 1971a ,b, 1975 ), although we cannot explain the apparent swelling of the mitochondrial matrix. The decrease in the number of peroxisomes was not reported by these authors. As the half-life of peroxisomes is about 1.5-2 days (de Duve & Baudhuin, 1966) , a 70% decrease in the peroxisomal population during 16-18 h cannot be accounted for by simple blockage of their biogenesis. Specific autophagy of peroxisomes might have occurred. This explanation has been evoked in two conditions, in a patient with a major liver metabolic imbalance (Landrieu et al., 1982) and in the course of a continuous clofibrate treatment in mice (Vamecq & Van Hoof, 1984) . In our experiments, only one animal out of seven displayed an apparent excess of peroxisomes in autophagic vacuoles. The simple explanation of autophagic destruction of peroxisomes would, however, not explain the persistence of the activity of most peroxisomal enzymes in the livers of rats treated with hypoglycin. Therefore, alternative explanations such as, for example, leaking or lysis of peroxisomal membranes must be considered.
The rapid toxicity of pent-4-enoate explains why little significant abnormality was detected in the hepatocytes, except for the prominent accumulation of very osmiophilic fat droplets, suggesting the presence of large amounts of unsaturated lipid. The same amount of lipid accumulated in rat liver within 40min after pent-4-enoate and within 17 h after hypoglycin treatment (Table 2) . Occasionally, a limited stacking of the cristae was observed in mitochondria from rats treated with pent-4-enoate. Similar stacking has been observed in hepatic mitochondria of rats given small doses of hypoglycin (10mg/kg body wt.) for 10 days (Brooks & Audretsch, 1975) and in riboflavin-deficient rats (Sugiska et al., 1969) . The mitochondrial acyl-CoA dehydrogenases that are inactivated by hypoglycin metabolites are flavoproteins.
The administration of clofibrate induced the expected 6-fold increase in the peroxisomal population in hepatocytes, which was not altered by treatment with either hypoglycaemic toxin. It must be stressed, however, that morphometric analysis also disclosed an increase in the volume fraction of mitochondria which is of similar absolute magnitude (22.2 to 29.5%; Table 2 ). This increase also was largely unaffected by the subsequent administration of either toxin.
Biochemical changes
Effects of hypoglycin. Incomplete oxidation of acyl groups after hypoglycin poisoning is thought to result from the inhibition of butyryl-CoA dehydrogenase by methylenecyclopropylacetylCoA (Osmundsen & Sherratt, 1975) , which forms irreversible adducts with the FAD prosthetic group (Wenz et al., 1981) . Butyryl-CoA accumulates in the matrix and is thought to be hydrolysed by the high-Km short-chain acyl-CoA hydrolase, allowing recycling of CoA and liberation of free butyrate. The total CoA content of normal rat liver mitochondrial fractions (about 2nmol/mg of protein; Holland is much less (at least 4-12 times) than the amounts of decanoylcarnitine shown to be oxidized in our experiments. This is also less than the maximum possible CoA content in mitochondria from clofibrate-fed rats (see Mannaerts et al., 1978) . f-Oxidation would have ceased unless butyryl-CoA formed was deacylated, allowing CoA to recycle (see Osmundsen & Sherratt, 1975 ), yet the extent of the second phase of oxygen uptake was always proportional to the amount of substrate added.
A remarkable finding was that coupled, but not uncoupled, liver mitochondria from hypoglycintreated rats fed with clofibrate oxidized decanoylcarnitine to the same extent (probably to acetoacetate), but with a biphasic time course (Fig. 5) . The kinetics of decanoylcarnitine oxidation suggest that, in addition to the classical butyryl-CoA dehydrogenase present, clofibrate feeding induces another butyryl-CoA dehydrogenase in the mitochondrial matrix which is not inactivated by iiethylenecyclopropylacetyl-CoA and which is apparently only active when the mitochondria are energized. Such an enzyme may represent the remaining butyryl-CoA dehydrogenase activity in the livers of clofibrate-fed rats given hypoglycin.
Its activity is also assumed to be insufficient to metabolize all the butyryl-CoA as quickly as it is formed during the first phase of oxygen uptake, but its contribution would also account for the faster rate during this phase of oxygen uptake compared with uncoupled mitochondria (Fig. 5) formed from 20 gLM-decanoylcarnitine) or even 1.0mM-butyrate to coupled mitochondrial fractions from clofibrate-fed rats or from clofibrate-fed rats given hypoglycin.
The mechanism of the partial protective effect of clofibrate feeding against inhibition of ,Boxidation found in vitro remains unknown, but if this also occurs in vivo it could explain the protection against hypoglycin toxicity. Further evidence that clofibrate does not prevent all the changes caused by hypoglycin is that the massive and complex organicaciduria found in poisoned rats (Tanaka, 1972 ) is decreased, but not prevented, by clofibrate feeding (R. K. Veitch & H. S. A. Sherratt, unpublished work).
Hypoglycin had almost no effect on the activities of the liver peroxisomal enzymes that we measured. It also did not affect significantly the response to clofibrate of these enzymes. It must be stressed, however, that not all biochemical functions of the peroxisomes were investigated.
Effects ofpent-4-enoate. Pent-4-enoate must first be converted into pent-4-enoyl-CoA in the mitochondrial matrix . With low concentrations of pent-4-enoate and physiological concentrations of CO2, pent-4-enoyl-CoA is metabolized by the pathway pent-4-enoyl-CoA-+ penta-2,4-dienoyl-CoA-pent-2-enoyl-CoA-+3-hydroxypentanoyl-CoA-_3-oxopentanoyl-CoA + CoA-+propionyl-CoA + acetyl-CoA (Hiltunen et al., 1978) .
Pent-2-enoyl-CoA is formed in coupled mitochondria by a reduction by NADPH of penta-2,4-dienoyl-CoA catalysed by enoyl-CoA reductase (Borrebaek et al., 1980) . When this pathway is overloaded by high concentrations of pent-4-enoate, hydration of penta-2,4-dienoyl-CoA competes with reduction, to give 3-hydroxypent-4-enoyl-CoA, which is oxidized to 3-oxopent-4-enoyl-CoA, which inactivates 3-oxoacyl-CoA thiolase (EC 2.3.1.16) (Schulz, 1983) . Borrebaek et al. (1980) showed that clofibrate feeding increases the specific activity of the NADPH-linked enoylCoA reductase 4-fold in rats, preventing the metabolism of penta-2,4-dienoyl-CoA to inhibitory products, since NADPH is formed in energized mitochondria by the energy-linked transhydrogenase (Borrebaek et al., 1980) . A further difference -between poisoning by pent-4-enoate and by hypoglycin may be that 4-enoyl-CoA reductase is inhibited by hypoglycin metabolites (see Sherratt & Veitch, 1984) . Conclusions The mechanisms of action of the hypoglycaemic toxins hypoglycin and pent-4-enoate have been extensively investigated (for references, see Sherratt & Osmundsen, 1976; Billington et al., 1978a,b; Billington, 1979; Sherratt, 1981; Sherratt et al., 1985) . However, their effects on intermediary metabolism are still only partly understood (L. Hue & H. S. A. Sherratt, unpublished work) . The use of these toxins as tools revealed quite unexpected changes in the enzyme systems for oxidizing fatty acids in mitochondria after clofibrate feeding. Chronic feeding of very-long-chain fatty acids also causes some increase in peroxisomal fl-oxidation, but less than that produced by clofibrate and its analogues . Some enzyme changes may constitute an adaptive mechanism to protect animals against the toxic effects of unusual fatty acids which may be ingested chronically in their diet, and the changes caused by clofibrate may be an exaggeration of this natural response. It is remarkable that clofibrate protects rats against the hypoglycaemic and toxic effects of two toxins which inhibit mitochondrial fl-oxidation in different ways. Further, the mechanism of protection against each toxin appears to be different.
The possible application of some of these findings to human pathology is speculative. Fibrate drugs increase the capacity of liver mitochondrial fl-oxidation in both rodents and primates (Capuzzi et al., 1983) , but the extent of induction of peroxisomal fl-oxidation in nonrodent species is controversial (Kindl & Lazarow, 1982; Reddy & Lalwani, 1983) . Induction of increased mitochondrial fl-oxidation activity might be useful in the treatment of some inborn errors of metabolism where there may be impaired mitochondrial fl-oxidation. This would come in addition to the well-known use of these drugs in hypercholesterolaemia and hypertriglyceridaemia.
